Table 2. Discharge and respiratory outcomes (highest requirement during admission) for all patients with known disposition categorized by sex, race, ethnicity and Elixhauser comorbidities.
Discharged | No Oxygen | Low Flow | High Flow | Noninvasive | Invasive | Discharged Alive | Expired | |
---|---|---|---|---|---|---|---|---|
n | 2152 | 430 | 809 | 511 | 73 | 329 | 1847 | 305 |
Sex | ||||||||
Male (%) | 1122 (52.1) | 196 (45.6) | 379 (46.8) | 296 (57.9) | 36 (49.3) | 215 (65.3) | 947 (51.3) | 175 (57.4) |
Race (%) | ||||||||
American Indian or Alaska Native | <10 (<0.5) | 0 (0.0) | <5 (<0.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | <10 (<0.5) | 0 (0.0) |
Asian | 44 (2.0) | 8 (1.9) | 13 (1.6) | 13 (2.5) | <5 (<6.8) | <10 (<3.0) | 38 (2.1) | <10 (<3.3) |
Black | 544 (25.3) | 110 (25.6) | 209 (25.8) | 111 (21.7) | 14 (19.2) | 100 (30.4) | 475 (25.7) | 69 (22.6) |
Hawaiian/Pacific Islander | <10 (<0.5) | 0 (0.0) | <5 (<0.6) | <5 (<1.0) | 0 (0.0) | <10 (<3.0) | <10 (<0.5) | <10 (<3.3) |
Other | 497 (23.1) | 107 (24.9) | 166 (20.5) | 110 (21.5) | 15 (20.5) | 99 (30.1) | 454 (24.6) | 43 (14.1) |
Unknown/Not Stated | 37 (1.7) | 7 (1.6) | 19 (2.3) | <5 (<1.0) | <5 (<6.8)) | <10 (<3.0) | 37 (2.0) | 0 (0.0) |
White | 1021 (47.4) | 198 (46.0) | 397 (49.1) | 272 (53.2) | 41 (56.2) | 113 (34.3) | 836 (45.3) | 185 (60.7) |
Ethnicity (%) | ||||||||
Hispanic or Latino | 560 (26.0) | 125 (29.1) | 196 (24.2) | 111 (21.7) | 18 (24.7) | 110 (33.4) | 511 (27.7) | 49 (16.1) |
Not Hispanic or Latino | 1557 (72.4) | 302 (70.2) | 596 (73.7) | 393 (76.9) | 55 (75.3) | 211 (64.1) | 1308 (70.8) | 249 (81.6) |
Unknown/Not Stated | 35 (1.6) | 3 (0.7) | 17 (2.1) | 7 (1.4) | 0 (0.0) | 8 (2.4) | 28 (1.5) | 7 (2.3) |
Age (%) | ||||||||
18–34 | 146 (6.8) | 73 (17.0) | 35 (4.3) | 18 (3.5) | 4 (5.5) | 16 (4.9) | 145 (7.9) | 1 (0.3) |
35–44 | 181 (8.4) | 61 (14.2) | 58 (7.2) | 28 (5.5) | 4 (5.5) | 30 (9.1) | 176 (9.5) | 5 (1.6) |
45–54 | 257 (11.9) | 54 (12.6) | 104 (12.9) | 48 (9.4) | 8 (11.0) | 43 (13.1) | 248 (13.4) | 9 (3.0) |
55–64 | 435 (20.2) | 67 (15.6) | 166 (20.5) | 101 (19.8) | 14 (19.2) | 87 (26.4) | 399 (21.6) | 36 (11.8) |
65–74 | 402 (18.7) | 60 (14.0) | 171 (21.1) | 81 (15.9) | 17 (23.3) | 73 (22.2) | 351 (19.0) | 51 (16.7) |
75–84 | 373 (17.3) | 58 (13.5) | 137 (16.9) | 104 (20.4) | 18 (24.7) | 56 (17.0) | 278 (15.1) | 95 (31.1) |
85+ | 358 (16.6) | 57 (13.3) | 138 (17.1) | 131 (25.6) | 8 (11.0) | 24 (7.3) | 250 (13.5) | 108 (35.4) |
Comorbidity (%) | ||||||||
AIDS/HIV | 32 (1.5) | 3 (0.7) | 13 (1.6) | 8 (1.6) | 3 (4.1) | 5 (1.5) | 28 (1.5) | 4 (1.3) |
Alcohol abuse | 175 (8.1) | 35 (8.1) | 68 (8.4) | 39 (7.6) | 6 (8.2) | 27 (8.2) | 151 (8.2) | 24 (7.9) |
Blood loss anemia | 142 (6.6) | 16 (3.7) | 62 (7.7) | 37 (7.2) | 5 (6.8) | 22 (6.7) | 98 (5.3) | 44 (14.4) |
Cardiac arrhythmias | 801 (37.2) | 134 (31.2) | 318 (39.3) | 215 (42.1) | 27 (37.0) | 107 (32.5) | 639 (34.6) | 162 (53.1) |
Chronic pulmonary disease | 716 (33.3) | 110 (25.6) | 281 (34.7) | 195 (38.2) | 32 (43.8) | 98 (29.8) | 587 (31.8) | 129 (42.3) |
Coagulopathy | 264 (12.3) | 39 (9.1) | 109 (13.5) | 64 (12.5) | 7 (9.6) | 45 (13.7) | 201 (10.9) | 63 (20.7) |
Congestive heart failure | 493 (22.9) | 61 (14.2) | 197 (24.4) | 145 (28.4) | 19 (26.0) | 71 (21.6) | 380 (20.6) | 113 (37.0) |
Deficiency anemia | 407 (18.9) | 65 (15.1) | 162 (20.0) | 106 (20.7) | 19 (26.0) | 55 (16.7) | 323 (17.5) | 84 (27.5) |
Depression | 636 (29.6) | 101 (23.5) | 253 (31.3) | 182 (35.6) | 27 (37.0) | 73 (22.2) | 526 (28.5) | 110 (36.1) |
Diabetes, complicated | 623 (28.9) | 87 (20.2) | 232 (28.7) | 159 (31.1) | 27 (37.0) | 118 (35.9) | 499 (27.0) | 124 (40.7) |
Diabetes, uncomplicated | 809 (37.6) | 127 (29.5) | 305 (37.7) | 199 (38.9) | 33 (45.2) | 145 (44.1) | 658 (35.6) | 151 (49.5) |
Drug abuse | 172 (8.0) | 34 (7.9) | 60 (7.4) | 41 (8.0) | 8 (11.0) | 29 (8.8) | 151 (8.2) | 21 (6.9) |
Fluid and electrolyte disorders | 904 (42.0) | 149 (34.7) | 338 (41.8) | 242 (47.4) | 41 (56.2) | 134 (40.7) | 721 (39.0) | 183 (60.0) |
Hypertension, complicated | 615 (28.6) | 78 (18.1) | 237 (29.3) | 176 (34.4) | 25 (34.2) | 99 (30.1) | 478 (25.9) | 137 (44.9) |
Hypertension, uncomplicated | 1386 (64.4) | 234 (54.4) | 537 (66.4) | 365 (71.4) | 46 (63.0) | 204 (62.0) | 1133 (61.3) | 253 (83.0) |
Hypothyroidism | 448 (20.8) | 66 (15.3) | 183 (22.6) | 121 (23.7) | 14 (19.2) | 64 (19.5) | 353 (19.1) | 95 (31.1) |
Liver disease | 283 (13.2) | 56 (13.0) | 104 (12.9) | 69 (13.5) | 10 (13.7) | 44 (13.4) | 232 (12.6) | 51 (16.7) |
Lymphoma | 29 (1.3) | 6 (1.4) | 10 (1.2) | 10 (2.0) | 73 (100.0) | 3 (0.9) | 23 (1.2) | 6 (2.0) |
Metastatic cancer | 140 (6.5) | 24 (5.6) | 55 (6.8) | 42 (8.2) | 4 (5.5) | 15 (4.6) | 111 (6.0) | 29 (9.5) |
Obesity | 682 (31.7) | 112 (26.0) | 264 (32.6) | 161 (31.5) | 29 (39.7) | 116 (35.3) | 582 (31.5) | 100 (32.8) |
Other neurological disorders | 541 (25.1) | 66 (15.3) | 225 (27.8) | 153 (29.9) | 20 (27.4) | 77 (23.4) | 414 (22.4) | 127 (41.6) |
Paralysis | 117 (5.4) | 9 (2.1) | 46 (5.7) | 35 (6.8) | 7 (9.6) | 20 (6.1) | 96 (5.2) | 21 (6.9) |
Peptic ulcer disease, excluding bleeding | 113 (5.3) | 22 (5.1) | 46 (5.7) | 32 (6.3) | 2 (2.7) | 11 (3.3) | 90 (4.9) | 23 (7.5) |
Peripheral vascular disorders | 521 (24.2) | 69 (16.0) | 200 (24.7) | 155 (30.3) | 25 (34.2) | 72 (21.9) | 400 (21.7) | 121 (39.7) |
Psychoses | 206 (9.6) | 32 (7.4) | 80 (9.9) | 67 (13.1) | 7 (9.6) | 20 (6.1) | 166 (9.0) | 40 (13.1) |
Pulmonary circulation disorders | 225 (10.5) | 36 (8.4) | 73 (9.0) | 65 (12.7) | 10 (13.7) | 41 (12.5) | 165 (8.9) | 60 (19.7) |
Renal failure | 513 (23.8) | 79 (18.4) | 186 (23.0) | 144 (28.2) | 19 (26.0) | 85 (25.8) | 392 (21.2) | 121 (39.7) |
Rheumatoid arthritis/collagen vascular diseases | 174 (8.1) | 27 (6.3) | 74 (9.1) | 40 (7.8) | 8 (11.0) | 25 (7.6) | 139 (7.5) | 35 (11.5) |
Solid tumor without metastasis | 313 (14.5) | 43 (10.0) | 122 (15.1) | 88 (17.2) | 14 (19.2) | 46 (14.0) | 249 (13.5) | 64 (21.0) |
Valvular disease | 527 (24.5) | 74 (17.2) | 229 (28.3) | 141 (27.6) | 17 (23.3) | 66 (20.1) | 420 (22.7) | 107 (35.1) |
Weight loss | 356 (16.5) | 59 (13.7) | 140 (17.3) | 107 (20.9) | 8 (11.0) | 42 (12.8) | 277 (15.0) | 79 (25.9) |
Expired includes those that expired in the ED without known respiratory outcomes.